Home | Site Map | Help
Welcome

ACADIA Pharmaceuticals is a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders.

Learn more

 Programs

We are developing a portfolio of clinical-stage drug candidates aimed at large market opportunities in schizophrenia, Parkinson's disease psychosis, sleep maintenance insomnia, neuropathic pain and other central nervous system disorders. We currently have five mid-to-late stage programs in clinical development.

Learn more

 Technology

Our proprietary drug discovery platform combines target-based and chemistry-based technologies to enable efficient discovery of new compounds that may serve as potential treatments for significant unmet medical needs.

Learn more